56 related articles for article (PubMed ID: 7514142)
1. Into interferon.
Salaman JR
Eur J Surg Oncol; 1994 Jun; 20(3):251-2. PubMed ID: 7514142
[No Abstract] [Full Text] [Related]
2. [Marked reduction of BCR-ABL fusion chromosome positive cells with interferon therapy combined with short-term imatinib in chronic myelogenous leukemia].
Ajima A; Takayama N; Hasegawa Y; Kojima H; Nagasawa T
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1997-9. PubMed ID: 14650975
[TBL] [Abstract][Full Text] [Related]
3. Interferon induced severe digital ischaemia in chronic myeloid leukaemia--successful treatment using ketanserin.
Sachithanandan A; Cuthbert RJ; Barros d'Sa AA
Eur J Vasc Endovasc Surg; 2001 Nov; 22(5):474-6. PubMed ID: 11735190
[No Abstract] [Full Text] [Related]
4. [Interferons in the treatment of hematological diseases].
Jantunen E; Nousiainen T
Duodecim; 1998; 114(12):1240-7. PubMed ID: 11524770
[No Abstract] [Full Text] [Related]
5. The role of alpha-interferon in chronic myelogenous leukaemia in Imatinib era.
Franceschini R; Zoppi F; Garuti A; Gobbi M
J Exp Clin Cancer Res; 2004 Dec; 23(4):697-8. PubMed ID: 15743042
[No Abstract] [Full Text] [Related]
6. Interferon-induced lupus nephritis in a patient with chronic myeloid leukemia.
Goyal HK; Wadhwa J; Arora B; Dawar R; Agarwal SK; Singh D
Leuk Lymphoma; 2005 Mar; 46(3):481-2. PubMed ID: 15621844
[No Abstract] [Full Text] [Related]
7. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.
Frater JL; Tallman MS; Variakojis D; Druker BJ; Resta D; Riley MB; Hrisinko MA; Peterson LC
Am J Clin Pathol; 2003 Jun; 119(6):833-41. PubMed ID: 12817431
[TBL] [Abstract][Full Text] [Related]
8. Delayed cytogenetic response with prolonged interferon-alpha treatment in chronic myeloid leukemia patients: quantification of BCR-ABL transcript by competitive reverse transcription-polymerase chain reaction.
Perego RA; Nosari AM; Cornacchini G; Bianchi C; Corizzato M; Morra E
Haematologica; 2001 Oct; 86(10):1101-3. PubMed ID: 11602419
[No Abstract] [Full Text] [Related]
9. [The role of alpha-interferon therapy in chronic myeloid leukemia].
Udvardy M
Orv Hetil; 2000 Jan; 141(2):67-70. PubMed ID: 10686779
[TBL] [Abstract][Full Text] [Related]
10. Fatal bone marrow aplasia during interferon-a treatment in chronic myelogenous leukemia.
Chiusolo P; Sica S; Laurenti L; Piccirillo N; Giordano G; Leone G
Haematologica; 2000 Feb; 85(2):212. PubMed ID: 10681733
[No Abstract] [Full Text] [Related]
11. Successful allogeneic bone marrow transplant for chronic myeloid leukaemia despite previous interferon-induced cardiomyopathy.
Broady R; Hawkins T; Browett P; Palmer S
Bone Marrow Transplant; 1998 Apr; 21(8):833-4. PubMed ID: 9603410
[TBL] [Abstract][Full Text] [Related]
12. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
[TBL] [Abstract][Full Text] [Related]
13. e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?
Colla S; Sammarelli G; Voltolini S; Crugnola M; Sebastio P; Giuliani N
Haematologica; 2004 May; 89(5):611-3. PubMed ID: 15136228
[TBL] [Abstract][Full Text] [Related]
14. [Effect of retinoic acid on the cytogenetic remission in the first chronic phase of chronic myeloid leukemia treated with interferon].
Egyed M; Mihályfalvi Z; Kollár B; Rumi G; Keller E; Vass J; Fekete S
Orv Hetil; 2001 Nov; 142(44):2421-5. PubMed ID: 11766235
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
Schultheis B; Heissig B; Pasternak G; Hörner S; Hehlmann R
Folia Biol (Praha); 2000; 46(6):251-5. PubMed ID: 11140858
[TBL] [Abstract][Full Text] [Related]
16. [Effectiveness of treatment with native alpha-interferon (Wellferon) in patients with chronic myeloid leukemia].
Rukavitsyn OA
Vopr Onkol; 1997; 43(6):606-9. PubMed ID: 9479361
[No Abstract] [Full Text] [Related]
17. Clinical significance of dual color-dual fusion translocation fluorescence in situ hybridization in the detection of bcr/abl fusion gene.
Wu B; Zhou S; Song L; Liu X
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):364-6. PubMed ID: 12408765
[TBL] [Abstract][Full Text] [Related]
18. Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia.
Fiorani C; Sacchi S; Bonacorsi G; Cosenza M
Haematologica; 2000 Sep; 85(9):1006-7. PubMed ID: 10980653
[No Abstract] [Full Text] [Related]
19. Collection of Ph-negative progenitor cells from interferon responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilization.
Olavarria E; Parker S; Craddock C; Philpott N; Tiniakou M; Chase A; Kanfer E; Apperley JF; Goldman JM
Haematologica; 2000 Jun; 85(6):647-52. PubMed ID: 10870123
[TBL] [Abstract][Full Text] [Related]
20. [Alpha-interferons in the treatment of patients with chronic myeloid leukemia].
Abdulkadyrov KM; Udal'eva VIu; Rukavitsyn OA; Bessmel'tsev SS
Vopr Onkol; 1999; 45(4):387-92. PubMed ID: 10532097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
